Celiac Disease Market, Size, Share, Trends, Epidemiology Forecast till 2030

Posted on
by

Celiac Disease Market, Size, Share, Trends, Epidemiology Forecast till 2030

DelveInsight Business Research LLP
DelveInsight’s “Celiac Disease Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Celiac Disease (CD) , historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Celiac Disease (CD) also known as coeliac disease/non-tropical sprue or gluten-sensitive enteropathy, is defined as a chronic, multiple-organ small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in genetically predisposed people. It is a serious autoimmune disorder where the ingestion of gluten leads to damage in the small intestine; it is not an allergy caused by gluten.

 

Celiac Disease Epidemiology Insights 

  • The total prevalent population of Celiac Disease in 7 MM in 2017 was 6,334,993  
  • The maximum number of cases of Celiac Disease in the United States in 2017 was found in the age group of 19–39 years was 241,354

  • The total prevalent population of Celiac Disease in 2017
          Germany – 738,357
          The United Kingdom – 650,676
          Spain – 421,326
          Japan – 65,148

  • The cases of Celiac Disease in the United States in 2017
    • 238,048 – Males
    • 423,196 – Females

Celiac Disease Market

Celiac Disease market size in 7MM in 2017 was USD 1,242.8 Million 

 

Celiac Disease Market Drivers

  • Robust Pipeline Activity
  • Increase in Awareness
  • Increasing Prevalence and Diagnosed Prevalence in Europe

 

Celiac Disease Market Barriers

  • Economic Burden on Patients
  • Lack of Efficient Diagnosis
  • Differential Diagnosis

 

Request for sample pages

Table of contents

1. Key Insights

2. Executive Summary of Celiac Disease (CD)

3. Competitive Intelligence Analysis for Celiac Disease (CD)

4. Celiac Disease (CD) : Market Overview at a Glance

4.1. Celiac Disease (CD) Total Market Share (%) Distribution in 2017

4.2. Celiac Disease (CD) Total Market Share (%) Distribution in 2030

5. Celiac Disease (CD) : Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Patient Journey

7. Celiac Disease (CD) Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Celiac Disease (CD) Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Celiac Disease (CD) Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Celiac Disease (CD) Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Celiac Disease (CD) Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Celiac Disease (CD) Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Celiac Disease (CD) Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Celiac Disease (CD) Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Celiac Disease (CD) Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Celiac Disease (CD) Treatment and Management

8.2. Celiac Disease (CD) Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Celiac Disease (CD) Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Celiac Disease (CD) : Seven Major Market Analysis

13.1. Key Findings

13.2. Celiac Disease (CD) Market Size in 7MM

13.3. Celiac Disease (CD) Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Celiac Disease (CD) Total Market Size in the United States

15.1.2. Celiac Disease (CD) Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Celiac Disease (CD) Total Market Size in Germany

15.3.2. Celiac Disease (CD) Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Celiac Disease (CD) Total Market Size in France

15.4.2. Celiac Disease (CD) Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Celiac Disease (CD) Total Market Size in Italy

15.5.2. Celiac Disease (CD) Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Celiac Disease (CD) Total Market Size in Spain

15.6.2. Celiac Disease (CD) Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Celiac Disease (CD) Total Market Size in the United Kingdom

15.7.2. Celiac Disease (CD) Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Celiac Disease (CD) Total Market Size in Japan

15.8.3. Celiac Disease (CD) Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Celiac Disease (CD)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/